Jason Karlawish
speaker
1,378 appearances
5 recordings
1 series
first heard Feb 2021
last heard Dec 2023
Jason Karlawish’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Uh and I think that should be part of our future and I think we're well equipped to learn how to do that.
And this is where the revolution is really gonna rev up.
It's not about imaging, it's not about spinal fluid, it's about blood.
It's gonna get really bloody.
Um we
have the ability with plasma measures now and serum measures.
to measure town amyloid as well as other markers such as uh markers of neurodegeneration and and neuroinflammation.
Uh, one of the most compelling moments I thought at the Alzheimer's meetings in Amsterdam.
this past July was a presentation that showed that a blood spot meaning you stain a piece of paper and go analyze that with an ELISA, a blood spot test could measure P tau two seventeen as well as the blood test could.
Which has been as well shown to be as good as the imaging.
So we are at the ability now.
Yeah, so couple of things on the table here.
First point just in general is there are several different blood tests out there for several different biomarkers.
Quest is one of them for markers of amyloid.
I was talking about the P TAU two seventeen test, uh, which is a different test.
Uh there are several out there.
I do think the future is going to be these tests because their efficiencies are spectacular compared to imaging.
Imaging is extremely expensive and resource intensive.
All right, that's one point.
Yeah.
Showing 361–380 of 1,378 · page 19 of 69
← Previous
Next →